A Review of Informed Consent for Porcine Islet Xenotransplantation to Treat Type 1 Diabetes
Xenotransplantation · 2026-07 · 33 (4)
DOI: 10.1111/xen.70158 ↗Abstract
ABSTRACT Purpose The objective of this review is to map and synthesize the existing literature regarding informed consent for porcine islet xenotransplantation for the treatment of Type 1 Diabetes. Methods The search was conducted in May 2025 through the following databases: PubMed, SCOPUS, EMBASE, and CINAHL. Broad search strings were used to combine the text words “islet” AND “xenotransplantation” AND “consent” or similar permutations and combinations. Peer‐reviewed articles were included if they were published between January 1990 and May 2025 and written in English. The final search results were manually exported to a reference manager system (Zotero), and the PRISMA‐ScR flow diagram was created to depict the data extraction process. Results From 134 sources, 7 articles met eligibility for this scoping review. Although clinical studies have been sporadically conducted, there is a lack of literature describing informed consent for islet xenotransplantation. Conclusion This review highlighted a scarcity of scholarly discourse and published guidance on informed consent specifically in the context of islet xenotransplantation.
EUVIMED